Estimating cost-benefit of quarantine length for COVID-19 mitigation
View ORCID ProfileAndreas Eilersen, View ORCID ProfileKim Sneppen
doi: https://doi.org/10.1101/2020.04.09.20059790
Andreas Eilersen
1University of Copenhagen, Niels Bohr Institute, 2100 København Ø, Denmark
Kim Sneppen
1University of Copenhagen, Niels Bohr Institute, 2100 København Ø, Denmark
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted September 10, 2020.
Estimating cost-benefit of quarantine length for COVID-19 mitigation
Andreas Eilersen, Kim Sneppen
medRxiv 2020.04.09.20059790; doi: https://doi.org/10.1101/2020.04.09.20059790
Subject Area
Subject Areas
- Addiction Medicine (348)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2644)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12218)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4092)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2654)
- Health Policy (1004)
- Hematology (362)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (434)
- Neurology (3872)
- Nursing (209)
- Nutrition (577)
- Oncology (2025)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6520)
- Radiology and Imaging (1400)
- Respiratory Medicine (871)
- Rheumatology (407)
- Sports Medicine (342)
- Surgery (447)
- Toxicology (53)
- Transplantation (185)
- Urology (165)